Akero Therapeutics, Inc. Quarterly Operating Lease, Payments in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Akero Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2020 to Q3 2024.
  • Akero Therapeutics, Inc. Operating Lease, Payments for the quarter ending September 30, 2024 was $84K, a 3.7% increase year-over-year.
  • Akero Therapeutics, Inc. Operating Lease, Payments for the twelve months ending September 30, 2024 was $329K, a 3.46% increase year-over-year.
  • Akero Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $321K, a 2.89% increase from 2022.
  • Akero Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $312K, a 2.97% increase from 2021.
  • Akero Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $303K, a 44.3% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $329K $84K +$3K +3.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $326K $81K +$2K +2.53% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $324K $82K +$3K +3.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $321K $82K +$3K +3.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $318K $81K +$2K +2.53% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $316K $79K +$2K +2.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $314K $79K +$2K +2.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $312K $79K +$2K +2.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $310K $79K +$3K +3.95% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $307K $77K +$2K +2.67% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $305K $77K +$2K +2.67% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $303K $77K +$3K +4.05% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $300K $76K +$58K +322% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $242K $75K +$16K +27.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $226K $75K +$16K +27.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $210K $74K Oct 1, 2020 Dec 31, 2020 10-K 2022-02-25
Q3 2020 $18K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $59K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $59K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.